AI Platform Leverages Robotic Bronchoscopy Under 3D Fluoroscopic Guidance for Precision Biopsy
|
By HospiMedica International staff writers Posted on 02 Sep 2024 |
|
.jpg "Image: Optellum Virtual Nodule Clinic is the world’s first AI-powered clinical decision support software for early lung cancer diagnosis (Photo courtesy of Optellum)")
Lung cancer typically presents no symptoms until it is advanced, limiting treatment effectiveness and patient prognosis. However, leveraging the vast number of annual CT scans received by US patients—approximately 90 million, including those from emergency and cardiac assessments—could facilitate an "early detection system" to identify cancer before symptoms develop.
A pioneering integrated product concept from Optellum Ltd. (Oxford, UK) combines artificial intelligence (AI) with advanced robotics and imaging devices to enable precision biopsy and improve patient outcomes. The Optellum Virtual Nodule Clinic, which is the first FDA and CE-MDR-approved decision support tool for early-stage lung cancer, utilizes a Patient Discovery AI that employs Natural Language Processing. This, coupled with a clinically validated Lung Cancer Prediction (LCP) score that utilizes imaging AI/Radiomics and deep-learning neural networks, aids clinicians in identifying at-risk patients within a healthcare system and prioritizing them for further diagnostic procedures like biopsies.
The use of minimally invasive endobronchial biopsies, performed with robotic bronchoscopes under advanced imaging guidance, represents the cutting edge in diagnosing lung tissue. Integrating these technologies with Optellum’s Virtual Nodule Clinic AI platform promises to revolutionize the precision, speed, and efficiency of lung cancer diagnosis and treatment. Programs powered by Optellum’s AI have demonstrated their capability to efficiently manage larger volumes of patients, allowing clinicians to make more informed decisions regarding the necessity of interventions for small nodules. This synergistic blend of AI software, imaging, and biopsy technologies holds the potential to significantly enhance patient outcomes by ensuring more accurate diagnoses and optimizing clinical workflows.
"We are thrilled to enable interventional pulmonologists using advanced bronchoscopy platforms to grow their programs through Optellum AI-powered early diagnosis and precision intervention," said Václav Potěšil, PhD, Founder & Chief Business Officer at Optellum. "Our goal is to move beyond early lung cancer diagnosis alone, to build an AI-powered lung "operating system" that drives the right patients into the right minimally invasive therapies, saving thousands of lives."
Related Links:
Optellum Ltd.
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
